Prolotherapy Research - Articular Cartilage Regeneration

Previous Page

 

A Scientific Editorial - Articular Cartilage Regeneration

Call to Action

Here are some suggestions to those with degenerated joints that were regenerated with Prolotherapy, and for those who use Prolotherapy in their practices. Let’s start obtaining before and after Prolotherapy X-rays, and if possible even MRIs. Make sure the X-rays and MRIs taken after Prolotherapy are compared to the ones taken before Prolotherapy, and are evaluated by an independent radiologist who understands that the patient had Prolotherapy. I believe that you will most likely see structures be regenerated! The average radiologist has never seen menisci or cartilage tissue regeneration. Tell him you performed (or received if you are the patient) Prolotherapy on the joint. Ask him specifically if he sees regeneration of articular cartilage, menisci, ligaments and any other structures? Do not be surprised when the radiologist says, “yes.” Send us the films to be published in the Journal of Prolotherapy. Perhaps then we can eliminate some of the skepticism about Prolotherapy and people can receive the treatments they really need, such as Prolotherapy. At least one of the myths that prevails in the world of orthopedics, that articular cartilage does not regenerate, will be dismissed once and for all. We can then rejoice because people with pain will get the treatments they need. Perhaps people everywhere will finally understand that cartilage can be stimulated to repair, and that it is Prolotherapy that is needed to regenerate articular cartilage.

Resources

  1. Sandell L, et al. Articular cartilage and changes in Arthritis: Cell biology of osteoarthritis. Arthritis Research & Therapy. 2001; 3(2):107-113.
  2. Hamerman D. The biology of osteoarthritis. N Engl J Med. 1989; 320:1322-1330.
  3. Goldring MB. Osteoarthritis and cartilage: The role of cytokines in this disorder. Curr Rheumatol Rep. 2000;2:459-465.
  4. Meachim G, et al. Cell counts of normal and osteoarthritic articular cartilage in relation to the uptake of sulphate in vitro. Ann Rheum Dis. 1962;21:45-50.
  5. Mankin HJ, et al. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971;53A:523-537.
  6. Rothwell AG, et al. Chondrocyte multiplication in osteoarthritic articular cartilage. J Bone Joint Surg Brit. 1973;55:588-594.
  7. Ryu J, et al. Biochemical and metabolic abnormalities in normal and osteoarthritc human articular cartilage. Arthritis Rheum. 1984; 27:49-57.
  8. Sandy J, et al. In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. Arthritis Rheum. 1984;27:388-397.
  9. Eyre D, et al. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthritis. Biochem J. 1980;188:823-837.
  10. Lippiello L, et al. Collagen synthesis in normal and osteoarthritic cartilage. J Clin Invest. 1977;59:593-600.
  11. Sandell LJ, et al. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: Differential expression of the amino-propeptide. J Cell Biol. 1991; 114:1307-1319.
  12. Oganesian A, et al. Type IIA procollagen amino-propeptide is localized in human embryonic tissues. J Histol Cytochem. 1997;45: 1469-1480.
  13. Hering TM. Molecular biology of cartilage repair. In Osteoarthritic Disorders Edited by Kuettner K, et al, Rosemont, Illinois: American Association of Orthopaedic Surgeons, 1995;pp.329-340.
  14. Altman R, et al. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum. 1986;29:1039-1049.
  15. Aigner T, et al. Differential expression of collagen types I, II, II, and X in human osteophytes. Lab. Invest. 2005;73:236-243.
  16. Matyas JR, et al. Gene expression of type II collagens in chondro-osteophytes in experimental osteoarthritis. Osteoarthritis Cart. 1997;5:99-105.
  17. Pottenger LA, et al. The effect of marginal osteophytes on reduction of varus-valgus instability in osteoarthritic knees. Arthritis Rheum. 1990;33:853-858.
  18. Uchino M, et al. Growth factor expression in the osteophytes of the human femoral head in osteoarthritis. Clin Orthop Rel Res. 2000;pp.119-125.
  19. Colao A, et al. Reversibility of joint thickening in acromegalic patients: an ultrasonography study. Journal of Clinical Endocrinology and Metabolism. 1998;83:2121-2125.
  20. Colao A, et al. Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. European Journal of Endocrinology. 2003;148:31-38.
  21. Barkan A. Acromegalic arthropathy and sleep apnea. Journal of Endrocrinology. 1997;155:S41-S44.
  22. Chrisman OD. The effect of growth hormone on established cartilage lesions. Clinical Orthopedics. 1975;107:232-238.
  23. Sledge CB. Growth hormone and articular cartilage. Federation Proceedings. 1973;32:1503-1505.
  24. Smith R, et al. Growth hormone stimulates insulin-like growth factor actions on adult articular chondrocytes. Journal of Orthopaedic Research. 1989;7:198-207.
  25. Werther G, et al. Visual demonstration of growth hormone receptors on human growth plate chondrocytes. Journal of Clinical Endocrinology & Metabolism. 1990;70:1725-1731.
  26. Mankin H. The effect of aging on articular cartilage. Bull New York Acad. Med. 1968;44:545-552.
  27. Elliott H. Studies on articular cartilage. Am J Anat. 1936;58: 127-145.
  28. Telhag H. DNA synthesis in degenerated and normal joint cartilage in full-grown rabbits. Acta Orthop. Scandinavica. 1973;44: 604-610.
  29. Rothwell A, et al. Chondrocyte multiplication in osteoarthritis Articular Cartilage. Journal of Bone and Joint Surgery. 1973;55B: 588-594.
  30. O’Driscoll S. Current concepts review- The healing and regeneration of articular cartilage. Journal of Bone and Joint Surgery. 1998;80:1795-1812.
  31. Redman S, et al. The cellular responses of articular cartilage to sharp and blunt trauma. Osteoarthritis and Cartilage. 2004;12: 106-116.
  32. Mankin H. The response of articular cartilage to mechnical injury. Journal of Bone and Joint Surg Am. 1982;64:460-466.
  33. Lane J, et al. Anaerobic and aerobic metabolism in articular cartilage. Journal of Rheumatology. 1977;4:334-342.
  34. Schwartz R, et al. The effect of environmental pH on glycosaminoglycan metabolism by normal articular human chondrocytes. J Lab and Clin Med. 1976;87:198-205. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34.
  35. Smith T, et al. Role of growth hormone in glycosaminoglycan synthesis by articular cartilage. Nature. 1975;253:269-271.
  36. Guerne P, et al. Growth factor responsiveness of human articular chondrocytes in aging and development. Arthritis and Rheumatism. 1994;38:960-968.
  37. Hauser R, et al. Prolo Your Pain Away! Third Edition. Beulah Land Press, 2007;p.32.
  38. Hackett G. Joint stabilization. American Journal of Surgery. 1955; 89:968-973.
  39. Reeves K. Prolotherapy: present and future applications in soft tissue pain and disability. Physical Medicine and Rehabilitation Clinics of North America. 1995;6:917-925.
  40. IBID. Randomized prospective double-blind placebo-controlled study of dextrose Prolotherapy for knee osteoarthritis with or without ACL laxity. Alt Ther Health Med 2000;6(2):37-46.
  41. IBID. Randomized, prospective, placebo-controlled double-blind study of dextrose Prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: evidence of clinical efficacy. J Altern Complement Med. 2000;6(4):pp.311-320.
  42. Hauser R, et al. A retrospective study on dextrose Prolotherapy for unresolved knee pain at an outpatient charity clinic in rural Illinois. Journal of Prolotherapy. 2009;1:11-21.
  43. Hauser R, et al. Standard clinical X-ray studies document cartilage regeneration in five knees after Prolotherapy. Journal of Prolotherapy. 2009;1:22-28.

 

 

Previous Page

 
Recomended Reading

Journal of Prolotherapy